Michael J. Rybak, Pharm.D., M.P.H., Ph.D.
Wayne State University
H-index: 95
North America-United States
Top articles of Michael J. Rybak, Pharm.D., M.P.H., Ph.D.
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii | Antibiotics | Jacinda C Abdul-Mutakabbir Nana Sakyi Opoku Karen K Tan Peter Jorth Victor Nizet | 2024/1/4 |
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms | Microbiology Spectrum | Ashlan J Kunz Coyne Kyle Stamper Callan Bleick Razieh Kebriaei Susan M Lehman | 2024/2/27 |
Vancomycin Dosing Guidelines: Where Do We Go From Here? | Policy | Nicholas Rebold Michael Rybak FIDSA FIDP | 2024/2/26 |
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model | Antimicrobial Agents and Chemotherapy | Ashlan J Kunz Coyne Callan Bleick Kyle Stamper Razieh Kebriaei Arnold S Bayer | 2024/2/20 |
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections | Microbiology Spectrum | Amer El Ghali Ashlan J Kunz Coyne Kristen Lucas Molly Tieman Xhilda Xhemali | 2024/2/6 |
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study | Infectious Diseases and Therapy | Nicholas Rebold Sara Alosaimy Jeffrey C Pearson Brandon Dionne Ahmad Taqi | 2024/3/1 |
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 US regions from 2018 to 2022 | Microbiology Spectrum | Ashlan J Kunz Coyne Sara Alosaimy Kristen Lucas Abdalhamid M Lagnf Taylor Morrisette | 2024/1/11 |
Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic … | Antimicrobial Agents and Chemotherapy | Taylor Morrisette Kyle C Stamper Katherine L Lev Razieh Kebriaei Dana J Holger | 2023/6/15 |
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes | Antimicrobial agents and chemotherapy | Amer El Ghali Taylor Morrisette Sara Alosaimy Kristen Lucas Maria G Tupayachi-Ortiz | 2023/10/18 |
2110. Enhancing Antibiotic Efficacy Against Enterococcal faecium with Bacteriophage and Antimicrobial Peptides | Open Forum Infectious Diseases | Callan Bleick Kyle Stamper Sumaiya Mohib Shaylyn Avery Biswagit Biswas | 2023/12 |
Reply to Scheetz et al | Clinical Infectious Diseases | Sara Alosaimy Michael J Rybak George Sakoulas | 2023/4/15 |
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin | Infectious diseases and therapy | Razieh Kebriaei Jacinda C Abdul-Mutakabbir Kyle C Stamper Katherine L Lev Michael J Rybak | 2023/10 |
2118. Comparative Analysis of Cefiderocol Mono-and Combination Therapy for Multi-Drug Resistant Gram-negative Infections | Open Forum Infectious Diseases | Amer El Ghali Ashlan Kunz-coyne Kristen Lucas Molly Tieman Andrew Purdy | 2023/12 |
Optimization of phage-antibiotic combinations against Staphylococcus aureus biofilms | Microbiology Spectrum | Razieh Kebriaei Susan M Lehman Rahi M Shah Kyle C Stamper Ashlan J Kunz Coyne | 2023/6/15 |
2779. Early Administration of Ceftazidime-Avibactam for Carbapenem-Resistant Enterobacterales Is Associated with Improved Clinical Success | Open Forum Infectious Diseases | Ashlan J Kunz Coyne Kristen Lucas Elizabeth Shald M Gabriela Cabanilla Christine Yost | 2023/12 |
Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction | Kaylee E Caniff Nicholas Rebold Michael J Rybak | 2023/3 | |
Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients … | Open Forum Infectious Diseases | Ashlan J Kunz Coyne Carolina Orzol Michael P Veve Michael J Rybak | 2023/9 |
Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models | Antimicrobial Agents and Chemotherapy | Amer El Ghali Kyle Stamper Ashlan J Kunz Coyne Dana Holger Razieh Kebriaei | 2023/11/15 |
1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia | Open Forum Infectious Diseases | Kaylee E Caniff Ashlan J Kunz Coyne Michael J Rybak | 2023/12 |
Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections | Amer El‐Ghali Ashlan J Kunz Coyne Kaylee Caniff Callan Bleick Michael J Rybak | 2023/6 |
